1. Search Result
Search Result
Targets Recommended: PI4K MAP4K Oct3/4 FXR Serotonin Transporter
Results for "

1834612-06-4

" in MCE Product Catalog:
Cat. No. Product Name Target Research Areas
  • HY-132613
    Lumasiran sodium

    Others Metabolic Disease
    Lumasiran sodium, an investigational RNA interference (RNAi) therapeutic agent, reduces hepatic oxalate production by targeting glycolate oxidase. Lumasiran sodium reduces urinary oxalate excretion, the cause of progressive kidney failure in primary hyperoxaluria type 1 (PH1) .